When Foot Traffic Came To A Crawl, PacSun Turned to Predictive Analytics

 

A splendid new retail partnership emerged during the pandemic with Pacsun’s partnership with Antuit.ai. This marriage of retail and AI-driven SaaS solutions will help double Pacsun’s ship completes through predictive online ordering analytics tied to leveraging stores and online fulfillment centers. Michael Relich, Co-CEO of PacSun, and Yogesh Kulkarni, Co-CEO and Head of Customer Success for Antuit.ai, spoke with Gabrielle Bejarano on this exciting development.

“During the pandemic, our online sales grew substantially,” Relich said. “And you look what’s happening with the pure plays like Revolve and other pure-play brands, they’re growing, and they use analytics. They know who their customers are and are kind of at an advantage. So being a brick & mortar and hybrid dealer is something that we have to do to remain competitive.”

And when foot traffic slowed in stores due to the pandemic, Pacsun wanted to utilize that store inventory to fulfill those online order demands. But easier said than done. Doing it the wrong way could quickly erode profitability. They needed a partner who could help alleviate these inventory challenges to maximize efficiency. Enter Antuit.ai.

Kulkarni said the Gen Z shopper comes with high expectations and expects promises fulfilled online. “If they order a product, they want the product to be available; they want their size to be available. They want it available when they want it for the occasion they want to wear it. That sounds easy, but operationally it is very difficult, which means you have to anticipate demand, know where the demand is coming from, and place the product in the right location to fulfill that demand. You should be able to activate your stores to get that product in a reasonable amount of time to the customers.” All this orchestration and intelligence is what Antuit.ai supplies. 

More Stories Like This

Having Funding Isn’t Enough, Entrepreneurs of Color Need an Ecosystem of Resources

Bringing One-click Checkouts to Merchants of All Sizes

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More